Results 141 to 150 of about 17,153 (154)

Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis

Immunity, 2014
Nagendra Singh, Ashish Gurav, Sathish Sivaprakasam   +2 more
exaly  

Control of brain tumor growth by reactivating myeloid cells with niacin

Science Translational Medicine, 2020
Susobhan Sarkar, Reza Mirzaei, Manoj Kumar Mishra   +2 more
exaly  

Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients

BMJ, The, 2014
Daniel Keene MbCHb
exaly  

Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression

Science Translational Medicine, 2012
Graeme Semple, Samuel D Wright, Daniel J Rader   +2 more
exaly  

Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages

Circulation Research, 2020
Peiyuan Bai, Jiao Liu, Jing Wang
exaly  

Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin

Acta Pharmaceutica Sinica B, 2018
Haisheng He, Yi Lu
exaly  

Riboflavin, niacin, folate and vitamin B12 in commercial microalgae powders

Journal of Food Composition and Analysis, 2019
Minnamari Edelmann, Bhawani Chamlagain
exaly  

Potential of curcumin and niacin-loaded targeted chitosan coated liposomes to activate autophagy in hepatocellular carcinoma cells: An in vitro evaluation in HePG2 cell line

International Journal of Biological Macromolecules, 2023
exaly  

A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk

Nature Medicine
Zeneng Wang, Xinmin S Li, Marco Witkowski   +2 more
exaly  

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

European Heart Journal, 2013
exaly